bit.bio raised €89M in a Series B round in Nov 2021. The company is based in Cambridge, UK. Investors in the round: Arch Ventures, Charles River Laboratories, Foresite Capital and 4 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
